Gaila Palo
Nurse Practitioner · Coupeville, WANPI 1013495845
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Smith+Nephew at 24.1% of the total. 2025 is the largest year on record at $79, 4.0 times the $20 reported in 2021.
Across 9 payments — averaging $20.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$45
- Molnlycke Health Care US, LLC$24
- Hollister Incorporated$21
- Next Science LLC$21
- Convatec Inc.$20
- Organogenesis Inc.$20
- plus $35 from 2 others
What the payments were for
- Food & beverage$185100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 2 | $45 |
| Molnlycke Health Care US, LLC | 1 | $24 |
| Hollister Incorporated | 1 | $21 |
| Next Science LLC | 1 | $21 |
| Convatec Inc. | 1 | $20 |
| Organogenesis Inc. | 1 | $20 |
| Koya Medical, Inc. | 1 | $18 |
| Tactile Systems Technology Inc | 1 | $17 |
How this compares
$185 in reported general payments places this provider in the 70th percentile of 2,466 nurse practitioner providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levofloxacin | 11 | $63 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $54 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Coupeville
- Olga VoloshinaSeattle$279K
- Sandra ChristensenSeattle$244K
- Felicia ForrestLynnwood$206K
- Amaris MurphyBellevue$146K
- Sonia GlennieSeattle$78K
- Megan WildesTacoma$72K
- Kate KennedyBellevue$63K
- Vicki HainesPasco$57K
- Jessica ArmitageSumner$46K
- Lia Duque Estrada de BarrosSeattle$43K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.